Sagimet Biosciences Inc Series A (SGMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,470 | -28,562 | -18,176 | -45,567 | -29,366 |
| Depreciation Amortization | -689 | -761 | -535 | -1,253 | -1,197 |
| Other Working Capital | 3,240 | 2,539 | 2,664 | -1,048 | -4,710 |
| Other Operating Activity | 5,102 | 3,147 | 1,511 | 5,433 | 3,862 |
| Operating Cash Flow | $-33,817 | $-23,637 | $-14,536 | $-42,435 | $-31,411 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,802 | -9,877 | 3,413 | -61,683 | -71,533 |
| Investing Cash Flow | $-9,802 | $-9,877 | $3,413 | $-61,683 | $-71,533 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 275 | 1 | N/A | 105,864 | 105,864 |
| Other Financing Activity | 0 | 0 | 0 | -1,045 | -1,045 |
| Financing Cash Flow | $275 | $1 | $N/A | $104,819 | $104,819 |
| Beginning Cash Position | 75,840 | 75,840 | 75,840 | 75,139 | 75,139 |
| End Cash Position | 32,496 | 42,327 | 64,717 | 75,840 | 77,014 |
| Net Cash Flow | $-43,344 | $-33,513 | $-11,123 | $701 | $1,875 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,817 | -23,637 | -14,536 | -42,435 | -31,411 |
| Free Cash Flow | -33,817 | -23,637 | -14,536 | -42,435 | -31,411 |